Issue 95, 2019

Targeting immune checkpoint B7-H3 antibody–chlorin e6 bioconjugates for spectroscopic photoacoustic imaging and photodynamic therapy

Abstract

In this study, we constructed bioconjugates of targeting immune checkpoint B7-H3 antibody and chlorin e6 to treat non-small cell lung cancer under the guidance of spectroscopic photoacoustic and fluorescence imaging. The B7-H3–Ce6 conjugates could display effective tumor diagnosis and therapy and provide a novel approach for immunotherapy.

Graphical abstract: Targeting immune checkpoint B7-H3 antibody–chlorin e6 bioconjugates for spectroscopic photoacoustic imaging and photodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
03 Sep 2019
Accepted
15 Oct 2019
First published
17 Oct 2019

Chem. Commun., 2019,55, 14255-14258

Targeting immune checkpoint B7-H3 antibody–chlorin e6 bioconjugates for spectroscopic photoacoustic imaging and photodynamic therapy

L. Zhu, J. Liu, G. Zhou, H. M. Ng, I. L. Ang, G. Ma, Y. Liu, S. Yang, F. Zhang, K. Miao, T. C. W. Poon, X. Zhang, Z. Yuan, C. Deng and Q. Zhao, Chem. Commun., 2019, 55, 14255 DOI: 10.1039/C9CC06839B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements